Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

被引:0
|
作者
Hwan-Ching Tai
Bo Y Wang
Alberto Serrano-Pozo
Matthew P Frosch
Tara L Spires-Jones
Bradley T Hyman
机构
[1] National Taiwan University,Department of Chemistry
[2] University of Iowa Hospitals & Clinics,Department of Neurology
[3] Harvard Medical School,C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital
[4] University of Edinburgh,Centre for Cognitive and Neural Systems and the Euan MacDonald Centre for Motor Neurone Disease
[5] Harvard Medical School,MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital
关键词
Point Spread Function; Synaptic Terminal; Tauopathy; Postsynaptic Terminal; Stereological Counting;
D O I
暂无
中图分类号
学科分类号
摘要
The accumulation of neurofibrillary tangles in Alzheimer’s disease (AD) propagates with characteristic spatiotemporal patterns which follow brain network connections, implying trans-synaptic transmission of tauopathy. Since misfolded tau has been shown to transmit across synapses in AD animal models, we hypothesized that synapses in AD patients may contain misfolded tau. By immunofluorescence imaging of bipartite synapses from AD subjects, we detected tau protein in 38.4% of presynaptic and 50.9% of postsynaptic terminals. The pre/post distribution for hyperphosphorylated tau was 26.9%/30.7%, and for misfolded tau 18.3%/19.3%. In the temporal cortex, microscopic aggregates of tau, containing ultra-stable oligomers, were estimated to accumulate within trillions of synapses, outnumbering macroscopic tau aggregates such as tangles by 10000 fold. Non-demented elderly also showed considerable synaptic tau hyperphosphorylation and some misfolding, implicating the synapse as one of the first subcellular compartments affected by tauopathy. Misfolding of tau protein appeared to occur in situ inside synaptic terminals, without mislocalizing or mistrafficking. Misfolded tau at synapses may represent early signs of neuronal degeneration, mediators of synaptotoxicity, and anatomical substrates for transmitting tauopathy, but its actual role in these processes remain to be elucidated.
引用
收藏
相关论文
共 50 条
  • [41] Tau Oligomers Promote Microglial Activation. The Neuroimmunomodulation Hypothesis of Alzheimer's Disease (AD)
    Morales, I.
    Jimenez, J.
    Maccioni, R. B.
    NEUROIMMUNOMODULATION, 2011, 18 (06) : 392 - 393
  • [42] Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer's disease 
    Puangmalai, Nicha
    Sengupta, Urmi
    Bhatt, Nemil
    Gaikwad, Sagar
    Montalbano, Mauro
    Bhuyan, Arijit
    Garcia, Stephanie
    McAllen, Salome
    Sonawane, Minal
    Jerez, Cynthia
    Zhao, Yingxin
    Kayed, Rakez
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (04)
  • [43] Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer's disease
    Du, Fang
    Yu, Qing
    Kanaan, Nicholas M.
    Yan, Shirley ShiDu
    HUMAN MOLECULAR GENETICS, 2022, 31 (15) : 2498 - 2507
  • [44] Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease
    Maeda, S
    Sahara, N
    Saito, Y
    Murayama, S
    Ikai, A
    Takashima, A
    NEUROSCIENCE RESEARCH, 2006, 54 (03) : 197 - 201
  • [45] Regional tau deposition and glucose metabolism in patients with Alzheimer's disease.
    Baghel, Vivek
    Tripathi, Madhavi
    Bal, Chandrasekhar
    Kumar, Praveen
    Pradhan, Rashmita
    Yadav, Saroj
    Rajeev, Kumar
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [46] Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
    Nowell, Joseph
    Raza, Sanara
    Livingston, Nicholas R.
    Sivanathan, Shayndhan
    Gentleman, Steve
    Edison, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 (03) : 987 - 999
  • [47] Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
    Mattsson-Carlgren, Niklas
    Andersson, Emelie
    Janelidze, Shorena
    Ossenkoppele, Rik
    Insel, Philip
    Strandberg, Olof
    Zetterberg, Henrik
    Rosen, Howard J.
    Rabinovici, Gil
    Chai, Xiyun
    Blennow, Kaj
    Dage, Jeffrey L.
    Stomrud, Erik
    Smith, Ruben
    Palmqvist, Sebastian
    Hansson, Oskar
    SCIENCE ADVANCES, 2020, 6 (16)
  • [48] Docking for molecules that bind in a symmetric stack to Alzheimer's disease tau fibrils with SymDOCK
    Smith, Matthew S.
    Kunach, Peter
    Knight, Ian S.
    Kormos, Rian
    Pepe, Joseph G.
    Glenn, Isabella
    Irwin, John J.
    DeGrado, William F.
    Diamond, Marc I.
    Shahmoradian, Sarah H.
    Shoichet, Brian K.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 298A - 298A
  • [49] Tau filaments are tethered within brain extracellular vesicles in Alzheimer's disease
    Fowler, Stephanie L.
    Behr, Tiana S.
    Turkes, Emir
    O'Brien, Darragh P.
    Cauhy, Paula Maglio
    Rawlinson, Isadora
    Edmonds, Marisa
    Foiani, Martha S.
    Schaler, Ari
    Crowley, Gerard
    Bez, Sumi
    Ficulle, Elena
    Tsefou, Eliona
    Fischer, Roman
    Geary, Beth
    Gaur, Pallavi
    Miller, Chelsea
    D'Acunzo, Pasquale
    Levy, Efrat
    Duff, Karen E.
    Ryskeldi-Falcon, Benjamin
    NATURE NEUROSCIENCE, 2025, 28 (01) : 40 - 48
  • [50] Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies
    Florenzano, Fulvio
    Veronica, Corsetti
    Ciasca, Gabriele
    Ciotti, Maria Teresa
    Pittaluga, Anna
    Olivero, Gunedalina
    Feligioni, Marco
    Iannuzzi, Filomena
    Latina, Valentina
    Sciacca, Michele Francesco Maria
    Sinopoli, Alessandro
    Milardi, Danilo
    Pappalardo, Giuseppe
    Marco, De Spirito
    Papi, Massimiliano
    Atlante, Anna
    Bobba, Antonella
    Borreca, Antonella
    Calissano, Pietro
    Amadoro, Giuseppina
    ONCOTARGET, 2017, 8 (39) : 64745 - 64778